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Summary
Theeffect ofnervegrowth factor (NGF)on proliferation/differentiationofmast cells wasinvestigated
in vitro. Although NGFaloneneithersupportedcolony formationofbone marrow-derived cultured
mast cells (BMCMC) nor induced development of mast cell colonies from nonadherent bone
marrow cells (NBMC), addition ofNGF to the suboptimal dose ofinterleukin 3 (IL3) significantly
increased thenumbersofmast cell colonies produced by BMCMC or NBMC in methylcellulose.
When stimulated by IL3 alone, cells in mast cell colonies were not stainedby berberine sulfate,
a fluorescent dye. In contrast, mast cells developing in methylcellulose cultures obtaining both
11,3 and NGF were stainedby berberine sulfate. The fluorescence was abolishedby thetreatment
of heparinase but not of chondroitinase ABC, suggesting that mast cells stimulated by 11,,3 and
NGF produced and stored heparin proteoglycan. Thehistaminecontentof BMCMC maintained
by IL-3 was also increased by addition of NGF. Since BMCMC showed mucosal mast cell-like
phenotype, NGF appeared to induce thephenotypic change to connective tissue-type mast cells
(CTMC). In the culture containing BMCMC, 3T3 fibroblasts, andIL-3, thephenotypic change
of BMCMC to CTMC was observed as well. Since NGF was detected in this coculture and
since addition ofanti-NGF monoclonal antibody suppressed thephenotypic change, NGF produced
by fibroblasts appeared to induce the phenotypic change. Neither BMCMC alone nor IL3 alone
increased the concentration of NGF. Therefore, there is a possibility that BMCMC stimulated
by IL3 may induce the production and/or release of NGF by fibroblasts.
M
ast cell precursors that are derivedfrom themultipoten-
tial hematopoieticstem cell circulate in thebloodstream,
invade into tissues, and differentiate into two phenotypi-
cally distinct populations: connective tissue-type mast cells
(CTMC)t and mucosal mast cells (MMC). CTMC and
MMC aredistinguishable by location, histochemicalandbio-
chemical characteristics, electron microscopic features, and
T cell dependency (1-4). Murine bone marrow-derived cul-
tured mast cells (BMCMC), which develop in the presence
ofT cell-derived growth factors (IL-3, IL4, and IL9) (5, 6),
resemble MMC in their phenotype; both are stained with
alcian blue but not berberine sulfate, contain little or no cy-
1 Abbreviations used in thispaper . BMCMC, bone marrow-derived cultured
mast cell; CTMC, connective tissue-type mast cell; EGF, epidermal growth
factor; GM, granulocyte/macrophage; MMC, mucosal mast cell; NBMC,
nonadherent bone marrow cell; NGF, nerve growth factor; PMC, peritoneal
mast cell.
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toplasmic electron-dense granules, and low levels of hista-
mine (7-10). Coculture ofBMCMC with 3T3 fibroblast cell
lines induced a phenotypic change to CTMC-likecells (11),
indicating that fibroblasts may influence the phenotype of
mast cells. However, the exact role offibroblasts has notbeen
clarified.
Nerve growth factor (NGF) is a well-characterized neu-
rotropic polypeptide for thesurvival, development, andfunc-
tion of basal forebrain cholinergic neurons in the central
nervous system, as well as peripheral sympathetic and em-
bryonic sensory neurons (12-15). Despiteits name, NGFhas
been shown to elicit other biological effects on nonneuronal
tissues. Forexample, NGF modulatesboth T andBcell-medi-
ated immune responses (16, 17), induces shape changes in
platelets (18), enhances the viability and functional proper-
ties ofneutrophils (19), and accelerates wound healing (20).
Recently, we demonstrated that NGF promoted human
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tive fashion to induce the differentiation of eosinophils and
histamine-containing cells (basophils or mast cells) (21, 22).
Aloe and Levi-Montalcini (23) have shown that injections
of NGF into neonatal rats result in the significant increase
ofmast cellsin various tissues. Since NGF is. secreted by fibro-
blasts (24), there is apossibility that developmentof CTMC-
like mast cells in the coculture of BMCMC and fibroblasts
is mediated by NGF released from fibroblasts. In thepresent
study, we showed that NGF induced the phenotypic change
from BMCMC to CTMC-like cells and that colonies com-
posed of CTMC-like cells developed when murine bone
marrow cells were cultured in methylcellulose in the pres-
ence of IL3 and NGF.
Materials and Methods
Cell Suspensions.
￿
Male WBB6F,-+/+ mice were used at 10-15
wk of age. These mice were raised by mating WB females with
C57BL/6malesin ourlaboratory. Themethod to prepare cell sus-
pensions has been described (25).
Cytokines and Other Reagents.
￿
2.5S NGF purified from murine
submaxillary glands was kindly provided by Drs. A. M. Stanisz
andJ. Bienenstock (McMaster University, Ontario, Canada) (21).
Neurotropic biological activity of the preparations was measured
in thedissociated cell assay, using neonatal mouse superior cervical
ganglion neurons; half-maximal response was at 1 ng/ml. IL3
purified from WEHI-3 supernatant was akind gift from Dr.J. N.
Ihle (NationalCancer Institute, Frederick, MD)(26). HumanrIL1/3
was obtained from Otsuka Pharmaceutical Co., Ltd. (Tokushima,
Japan). Murine rIL4, rIIL5, granulocyte/macrophage-CSF (GM-
CSF), and TNF-a were obtained from Genzyme (Boston, MA).
Murine epidermal growth factor (EGF) wasprovidedby Wako Pure
Chemical Industries, Ltd. (Osaka, Japan).. Purified murine IgGmAb
to 2.5S NGF (clone (31) was a kind gift from Dr. E. M. Shooter
(Stanford University, Stanford, CA).
BMCMC.
￿
Bone marrow cells of WBB6F,-+/+ mice were
cultured at a density of 106 cells/ml in a-MEM (Gibco Laborato-
ries, Grand Island, NY) supplemented with 10-° M 2-ME (Sigma
Chemical Co., St. Louis, MO), 10% FCS (Hyclone Labs, Logan,
UT), and 10% PWM-stimulated spleen cell-conditioned medium
(PWM-SCM). The method to prepare PWM-SCM has been de-
scribed (27), andPWM-SCMcontains IL3, 114, andprobably IL-9
(6, 28). Cultureflasks (Nunc, Roskilde, Denmark) were incubated
at 37°C in a humidified atmosphere of 5% CO2, 95% air. Half
of the medium was replaced every 7 d. As described by Nakano
et al. (10), >95% of cells were identified as immature mast cells
4 wk after the initiation of the culture; the cells were harvested,
washed, and resuspended in a-MEM.
Clonal Cell Culture.
￿
Methylcelluloseculture wascarried outby
using a modification of the technique described by Nakahata et
al. (27). Bone marrow cells obtained from femurs and tibias of
WBB6F,-+/+ mice were suspended in MEM containing 10%
FCS andallowed to adhere in plastic culture flask (Nunc) for 2 h
at 37°C. The resulting nonadherent bone marrow cells (NBMC)
were resuspended in a-MEM. 10^ BMCMC or 5 x 10" NBMC
were cultured in 1 ml of a-MEM containing 0.9% methylcellu-
lose (Sigma Chemical Co.), 30% FCS, 10 -' M 2-ME, 1% BSA
(Sigma Chemical Co.), 50 U/ml penicillin, and 50 mg/ml strep-
tomycin in the presence of 50 U/ml 11,3 with or without other
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cytokines at 37°C in a humidified atmosphere flushed with 5%
COz in air. As a control, 50 ng/ml cytochrome C (Sigma Chem-
ical Co.) wasaddedto methylcellulose culture instead ofcytokines.
20 daftertheinitiation of theculture, mast cell colonies containing
>20cells were identified accordingto thecriteria describedby Naka-
hata et al. (27) and counted under an inverted microscope.
Staining.
￿
Individual colonies were picked up from methylcel-
lulose cultures by aPasteur pipette underdirect microscopic visual-
ization and placed onto glass slides. The preparations were fixed
in Camoy'sfluid and stainedwith 0.025%berberinesulfate(Sigma
Chemical Co.) at pH 2.5.Berberinesulfateis afluorescent dyethat
specifically stains heparin (3, 9, 29). To confirm the specificity of
staining, some specimens were treated with either heparinase
(heparin lyase from Flavobacterium heparium; Seikagaku Chemical
Industry Co. Ltd., Tokyo, Japan) or with chondroitinase ABC
(chondroitin ABClyasefrom Proteus vulgaris, Seikagaku Chemical
Industry Co. Ltd.) before staining according to the method de-
scribed by Nakano et al. (10). Specimens were fixedin chilledcal-
cium acetate formalin at 4°Cfor 18 h and overlaid with heparinase
or chondroitinase ABC dissolved in 0.1 M Tris-HCI buffer at the
concentration of0.5 IU/ml (pH7.0) or 5.0 IU/ml(pH 8.0), respec-
tively. Afterwashing with Tris-buffer of the same pH, specimens
were stained with berberine sulfate. Fluorescent intensity of cells
in mast cell colonies was determined by using asystemphotometer
(OSP-1; OlympusJapanCo. Ltd., Tokyo, Japan), whichcan detect
the fluorescence of individual cells stained with berberine sulfate.
Afterthemeasurement offluorescent intensity, the same specimens
were stained with alcian blue at pH 2.5.
Coculture of mast cells and fibroblasts (see below) was tryp-
sinized, and the cells were washed with PBS and spun with a
cytocentrifuge (Cytospin, Shandon Southern, Elliott, IL) at 600
rpm for 5 min. The cytospin preparations were stained with ber-
berine sulfate and alcian blue as stated above.
Isolation ofPeritonealMast Cells (PMC).
￿
Murine PMCwere col-
lected according to the method described by Yurt et al. (30) .
WBB6F,-+/+ mice were intraperitoneally injected with 5 ml of
Tyrode's buffer containing 0.1%gelatin (Sigma Chemical Co.) . Peri-
toneal cellswere collected from lavage of theperitoneal cavity. After
washing with Tyrode's buffer containing 0.1% gelatin, 1 ml of the
cell suspension was layered on 2 ml of 22 .5% (wt/vol) metriza-
mide (Daiichi Pure Chemical Co. Ltd., Tokyo, Japan) and cen-
trifuged at room temperature for 15 min at 400g. The cell pellets
were washed, resuspended in a-MEM containing 10% FCS, and
spun in the cytocentrifuge.
Electron Microscopy.
￿
Some mast cell colonies were collected in
microcentrifuge tubescontaining 2.5%glutaraldehyde-2% parafor-
maldehyde solution and fixed at 4°C for 1 h. After washing with
PBS, the specimens were postfixed at 4°C for 2 h in 1% osmium
tetroxide, processed routinely, and then embedded in Epon 812.
Thin sections (60 nm thick) were stained with uranyl acetate and
lead citrate, and examined with an electron microscope (H-600;
Hitachi),
Histamine Assay.
￿
2 ml of a culture mixture containing 2 x
105 BMCMC, a-MEM, 10% FCS, antibiotics, and 100 U 11,3
with various amounts of NGF were layered onto 35-mm culture
dishes (Corning Grass Works, Coming, NY) andincubatedat 37°C
in a humidified atmosphere with 5% COZ in air. As a control,
100 ng cytochrome C was addedinto the culture instead of NGF.
Half of the medium was replaced 1 wk after the initiation of the
culture. 2 wk later, the cultured cells were harvested, washed,
resuspended in 0.4 ml PBS, and then thenumber ofmast cellswas
counted. Afteradding 0.1 ml of 12% perchloric acid, thecell sus-
pensions were stored at -80°C. Histamineconcentration wasde-termined by a fluorometric assaydescribed byShore et al. (31), and
the content of histamine per 105 mast cells was calculated.
Coculture ofBMCMCwith Fibroblasts.
￿
Coculture ofBMCMC
with 3T3-Swiss albino fibroblasts, obtained from the Japanese
Cancer Research Resources Bank, was carried out by using a
modification of the technique described by Levi-Schaffer et al. (11)
and Fujita et al. (32). Briefly, 105 BMCMC suspended in 2 ml of
a-MEM containing 10% FCS and antibiotics with or without 50
U/ml 11,3 were added onto a confluent monolayer of 3T3 fibro-
blasts in 35-mm culture dishes. The culture medium was collected
and replaced with 2 ml of fresh culture medium every 2 d. NGF
levels in the collected culture media were measured by an ELISA
using anti-NGF mAb (BoehringerMannheim Biochemicals, Mann-
heim, FRG) (33). 14 d after the initiation of the coculture, the
fluorescent intensityof mast cells after staining with berberine sul-
fate was examined in cytocentrifuge preparations of trypsinized
cultures.
In other experiments, 50 U/ml 11,3 and 10 NAg/ml anti-NGF
mAb (clone 01) were added into the coculture of BMCMC with
3T3 fibroblasts. Dishes were incubated for 2 wk at 37°C in a hu-
midified atmosphere with 5% COZ in air. The culture medium
was aspirated and replaced with 2 ml offresh culture medium with
IL3 and anti-NGF mAb every 2 d.
Results
Eject ofNGF on Mast Cell Colony Formation.
￿
104 murine
BMCMC were incubated in 1 ml of methylcellulose culture
with various doses of IL3. Without 11,3, no colonies devel-
oped for the incubation period of 20 d. Addition of IL3 at
doses of0.5-100 U/ml resulted in formation of mast cell colo-
nies, and the number of colonies was increased in a dose-
dependent manner (Fig. 1).
Since NGF promotes differentiation ofbasophilic cells con-
taining histamine from human peripheral blood (21) and cord
blood (22), we examined its effect on formation of mast cell
colonies from BMCMC and NBMC. NGF alone (50 ng/ml)
did not support colony formation of BMCMC, but addition
GOO .
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Figure 1.
￿
Colony formation ofBMCMC in the presence ofvarious con-
centrations of IL3. 104 BMCMC were cultured in methylcellulose, and
colonies were counted 20 d ofthe culture. Each value is expressed as means
± SE of three separate experiments performed in duplicate.
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of NGF (50 or 500 ng/ml) to a suboptimal dose of IL-3 (50
U/ml) significantly augmented the number ofcolonies (Table
1). The specificity of the effect of NGF was examined by using
mAb to 2.5S NGF. Addition of the anti-NGF mAb com-
pletely abolished the effect of NGF. CytochromeC (50 ng/ml)
did not affect development of mast cell colonies with or
without IL-3.
In the next experiment, differentiation of mast cells from
NBMC was examined. Addition of NGF (50 and 500 ng/ml)
to the suboptimal dose of IL-3 increased the number ofmast
cell colonies in a dose-dependent manner, whereas NGF alone
(50 ng/ml) had no effect on development of mast cell colo-
nies (Table 2). The effect of NGF was abolished by anti-NGF
mAb. Cytochrome C neither enhanced nor suppressed de-
velopment of mast cell colonies.
Fluorescent Intensity of Mast Cells Stained with Berberine Sul-
fate. Cells in mast cell colonies that developed in cultures
of BMCMC or NBMC in the presence of50 U/ml IL-3 were
stained with alcian blue (94% of cells in positive) but not
with berberine sulfate (100% of cells in negative), as reported
by several investigators (2-4, 7). When both 50 U/ml IL-3
and 50 ng/ml NGF were added to the cultures of BMCMC
or NBMC, the cells in mast cell colonies were stained not
only with alcian blue (97% ofcells in positive) but also with
berberine sulfate (92% of cells in positive).
Fluorescent intensity of each cell in mast cell colonies was
measured by the systemphotometer. The fluorescent inten-
sity of murine PMC, typed as CTMC, was decreased after
treatment with 0.5 IU/ml heparinase for 30 min, but not
after treatment with 5 IU/ml chondroitinase ABC for 4 h
(Table 3). Addition of 50 ng/ml NGF to 50 U/ml 11,3 in-
Table 1.
￿
Colony Formation by BMCMC Promoted by 2.SS NGF
Added factor(s)`
￿
No. of colonies
None
NGF (50 ng)
Cytochrome C (50 ng)
IL-3 (50 U)
IL-3 (50 U) +
IL-3 (50 U) +
IL-3 (50 U) +
IL-3 (50 U) + NGF (50 ng) +
anti-NGF mAb (20 Fg)
NGF (50 ng)
NGF (500 ng)
cytochrome C (50 ng)
mean ± SE
0
0
0
94±18
146±9x
313 ± 155
85 ± 11
69 ± 611
BMCMC were cultured in methylcellulose at a density of 104 cells/ml
with factor(s), and colonies were counted 20 d after the incubation. Each
value was obtained from three to five separate experiments performed
in duplicate.
Amounts are per milliliter.
#p < 0.05, when compared with IL-3 alone by Student's t test.
Sp < 0.001, when compared with IL-3 alone.
11 p < 0.001, when compared with IL-3 + NGF (50 ng).Table 2.
￿
Mast Cell Colony Formation by NBMC Promoted
by 2.SS NGF
Added factor(s)"
￿
No. of colonies
mean ± SE
None
￿
0
NGF (50 ng)
￿
0
Cytochrome C (50 ng)
￿
0
IL-3 (50 U)
￿
3.0 ± 0.7
IL-3 (50 U) + NGF (50 ng)
￿
6.0 ± 0.2t
IL-3 (50 U) + NGF (500 ng)
￿
12.6 ± 1.25
IL-3 (50 U) + cytochrome C (50 ng)
￿
2.8 ± 1.0
IL-3 (50 U) + NGF (50 ng) +
anti-NGF mAb (20 ug)
￿
3.2 ± 1.411
NBMC were cultured in methylcellulose at a densityof 5 x 10^ cells/ml
with factor(s), and mast cell colonies were counted 20 d after theincuba-
tion. Each value was obtained from four to eight separate experiments
performed in duplicate.
' Amounts are per milliliter.
t p < 0.01, when compared with IL-3 alone.
5 p < 0.001, when compared with IL-3 alone.
II p < 0.05, when compared with IL-3 + NGF (50 ng).
BMCMC and NBMC were cultured in methylcellulose at a density of 10° and 5 x 10^ cells/ml, respectively, and mast cell colonies were picked
up 20 d after the culture. The cells were stainedwith berberine sulfate, and fluorescent intensity of each cell was examined using the systemphotom-
eter. Each value represents mean ± SE of 100-250 cells.
' Amounts are per milliliter.
t Before staining with berberine sulfate, the cells were treated with either heparinase or chondroitinase ABC.
5p < 0.001, when compared with PMC which received heparinase treatment.
II p < 0.001, when compared with cells harvested from colonies that were stimulated by IL-3 alone.
10
￿
Mast Cell Differentiation
creased thefluorescent intensityof the mast cellsdeveloping
from either BMCMC or NBMC, and the value was com-
parable with that of PMC. The fluorescence was abolished
by heparinase treatment, butnot by chondroitinase ABC treat-
ment (Table 3) . Theeffect ofNGFwas abolishedby addition
of anti-NGF mAb (Table 3).
Electron Microscopic Features of the Cells in Mast Cell Colo-
nies. PMC and cultured mast cells were examined by the
electron microscope. PMCcontainednumerous homogeneous
electron-dense granules, but mast cellsdeveloped in the cul-
ture of BMCMC or NBMC stimulated by IIx3 alone pos-
sessed fewdensegranules and cytoplasmic vacuoles containing
flocculent materials (Fig. 2 A). In contrast, when BMCMC'
or NBMC were stimulated by both 11,3 andNGF, developing
mast cells became larger in size and contained abundant
electron-dense granules, andtheelectron microscopic features
resembled those of PMC (Fig. 2 B).
Effect ofNGFon Histamine ContentsofBMCMC. Because
histamine contents of CTMC are higher than those of
BMCMC or MMC(3, 34), we estimatedhistaminecontents
in BMCMC cultured for 2 wk in liquid medium containing
IL-3 and NGF. BMCMC cultured with a fixed dose of 11,3
(50 U/ml) and increasing doses of NGF showed a dose-
dependent increase of histamine contents to fivefold levels
(Table 4). In contrast, addition of 50 ng/ml cytochrome C
Table 3. Fluorescent Intensity of Mast Cells Stained with Berberine Sufate
Cells Added factor(s)' Enzyme treatmentt Fluorescent intensity
rlu/cell
PMC - 3.722 ± 0.1065
Heparinase 1.310 ± 0.198
Chondroitinase ABC 3.393 ± 0.1895
Cells from IL-3 (50 U) - 1.360 ± 0.018
BMCMC IL-3 (50 U) + NGF (50 ng) - 3.124 ± 0.08411
colony IL-3 (50 U) + NGF (50 ng) Heparinase 1.339 ± 0.106
IL-3 (50 U) + NGF (50 ng) Chondroitinase ABC 2.579 ± 0.12811
IL-3 (50 U) + NGF (50 ng) +
anti-NGF mAb (20 hg) 1.189 ± 0.061
Cells from IL-3 (50 U) - 1.084 ± 0.018
NBMC IL-3 (50 U) + NGF (50 ng) - 2.606 ± 0.05511
colony IL-3 (50 U) + NGF (50 ng) Heparinase 0.983 ± 0.078
IL-3 (50 U) + NGF (50 ng) Chondroitinase ABC 2.496 ± 0.20211
IL-3 (50 U) + NGF (50 ng) +
anti-NGF mAb (20 ug) 0.805 ± 0.0510 1 2 3 4
Fluoreseom lntonsicy
to 50 U/ml IL3 did not
BMCMC.The addition ofanti-NGFmAbabolishedthe effect
of NGF on histamine contents (Table 4) .
Effect ofVarious Cytokines on the Phenotypic Change.
￿
To
Table 4.
￿
Increase in Histamine Contents ofBMCMC Induced
by 25S NGF
Added factor(s)'
IL-3 (50 U)
IL-3 (50 U) + NGF (5 ng)
IL-3 (50 U) + NGF (50 ng)
IL-3 (50 U) + NGF (500 ng)
IL-3 (50 U) + cytochrome C (50 ng)
IL-3 (50 U) + NGF (50 ng) +
anti-NGF mAb (20 tug)
Figure 3.
￿
Effect of anti-NGF
mAbon the fluorescent intensity
ofmast cells stained with berber-
tine sulfate. BMCMC were cul-
tured with fibroblasts and II73,
with (O) and without (") anti-
NGF mAb.
increase histamine contents of
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BMCMC were incubated for 2wk in 35-mm culture dishes at a density
of 10 5 cells/ml in a-MEM containing 10% FCS, antibiotics, and fac-
tor(s) . Halfof themedium was replaced 1wk later . The histamine content
(mean ± SE) of the cells was determined for four separate experiments .
Amounts are per milliliter .
tp < 0.01, when compared with IL-3 alone .
5p < 0.001, when compared with IL-3 alone .
11 p < 0.01, when compared with IL-3 + NGF (5 ng) .
Figure 2.
￿
Electron microscopic features
of cells in mast cell colonies that devel-
oped after plating 5 x 104 NBMC in
methylcellulose: (A) culture medium con-
taining 11,3 (50 U/ml) alone ; (B) culture
medium containing both 11,3 and NGF
(50 ng/ml) . The former mast cell con-
tains several large vacuoles with floccu-
lent materials . In contrast, the latter mast
cell contains nearly homogeneous elec-
tron-dense granules (x10,000),
assess the specificity ofNGF, we further examined the effect
of other cytokines (í1710,11L4, IL5, EGF, GM-CSF, andTNF-
a) in methylcellulose cultureofBMCMC.A suboptimal dose
of IL3 (50 U/ml) was present in all cultures . The addition
of 100 U/ml ILlß, 50 U/ml IL5, 500 ng/ml EGF, or 10
ng/mlTNF-a neither increasedthenumber ofcolonies, nor
induced development ofberberine sulfate-positive mast cells
(Table 5) . The number of mast cell colonies was increased
in the culture supplemented with 100 U/mlIL4and 50U/ml
IL3 by more than three times as compared with IL3 alone,
and the number was decreased in the culture supplemented
with 50 U/ml GM-CSF and 50 U/ml 11,3 by half (Table 5) .
NeitherIL4 norGM-CSF affect the proportion ofberberine
sulfate-positive mast cells.
Table 5 .
￿
Colony Formation by BMCMC cultured with 50 U/ml
BMCMC were cultured in methylcellulose at a density of 104 cells/ml
with factor(s), and colonies were counted 20 d after the incubation . Each
value was obtained from two separate experiments performed in duplicate .
Amounts are per milliliter .
tp < 0.01, when compared with IL-3 alone .
5p < 0.05, when compared with IL-3 alone .
Histamine contents IL-3 and Various Cytokines
Added cytokines* No . of colonies
ng/105 cells
19 ± 2
41±4t mean ± SE
IL-3 135 ± 9
82±55
IL-3 + IL-10 (100 U) 112 ± 8
100±65
IL-3 + IL-4 (100 U) 514 ± 104
16 ± 4
IL-3 + IL-5 (50 U) 141 ± 4
18±1u
IL-3 + EGF (500 ng) 139 ± 8
IL-3 + GM-CSF (50 U) 60 ± 65
IL-3 + TW-tx (10 ng) 159 ± 21800
~_ . 600
é
d 400
Z
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Figure 4.
￿
Accumulative NGF levels in the culture medium offibroblast
monolayers. Four different conditions were examined: (a) fibroblast
monolayers; (b) ID3 alone added to fibroblast monolayers; (c) BMCMC
alone added to fibroblast monolayers; (d) both IL3 and BMCMC added
to fibroblast monolayers. Results are expressed as the mean values ofthree
separate experiments performed in duplicate.
Production ofNGF by Fibroblasts.
￿
We examined whether
NGF produced by fibroblasts is actually involved in the pheno-
typic change ofmast cells. BMCMC and 3T3 fibroblasts were
cocultured with or without IL-3. 2 wk after the initiation
of the coculture, mast cells harvested from the coculture con-
taining IL3 were strongly stained with berberine sulfate, but
mast cells harvested from the coculture without IL3 were
not . When anti-NGF mAb was added to the coculture con-
taining IL-3, no mast cells were stained with berberine sul-
fate (Fig. 3).
NGF levels were assessed by an ELISA in four different
culture conditions: (a) confluent monolayers alone; (b) IL3
(50 U/ml) added to the monolayers; (c) BMCMC added to
the monolayers; (d) both BMCMC and IL3 added to the
monolayers. NGF levels increased significantly only when both
BMCMC and IL3 were added (Fig. 4) .
Although NGF alone neither supported colony formation
of BMCMC nor induced development of mast cell colonies
from NBMC, addition of NGF to the suboptimal dose of
IL3 increased the numbers of mast cell colonies produced
by BMCMC or NBMC. For the proliferation of BMCMC,
IL4 has been reported to act synergistically with IL3 (35).
We thank Drs. J. Bienenstock, J. Marshall, and A. M. Stanisz (McMaster University, Ontario, Canada)
for helpful discussions and supplying pure NGF, and Dr. Ihle (National Cancer Institute, Frederick, MD)
for providing pure 1163. We also thank Dr. E. M. Shooter (Stanford University) for providing anti-NGF mAb.
This work was supported by a grant from the Ministry of Education, Science and Culture, Japan, and
by the BasicResearch Core System, the Special Coordination Fund for Promoting Science and Technology,
Japan.
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To our knowledge, the present report is the first one to de-
scribe the synergistic action of NGF.
The second effect of NGF on differentiation of mast cells
is induction ofCTMC-like mast cells. When NGF was added
to IL3, mast cells developing in methylcellulose cultures ap-
peared to contain more heparin than mast cells developing
in methylcellulose cultures without NGF. The histamine con-
tent of BMCMC maintainedby 11,3 was increased by addi-
tion of NGF. Although IL4 increased the number of mast
cell colonies, all cytokines examined in the present experi-
ment, including 11,4, did not induce the expression ofCTMC-
like phenotype.
Combination of staining with berberine sulfate and treat-
ment with heparinase or chondroitinase ABC is a useful
method to classify the subpopulation of mast cells. CTMC
are berberine sulfate positive, and the fluorescence is abol-
ished by the treatment of heparinasebut not ofchondroitinase
ABC (10, 29). This suggests that the heparinase-sensitive
fluorescence after staining with berberine sulfate represents
the content of heparin in mast cell granules. We quantita-
tively measured the fluorescent intensity by using the sys-
temphotometer. This system enables us to estimate the pheno-
type of individual mast cells.
Levi-Schaffer et al. (11) first reported that BMCMC ac-
quired CTMC-like phenotype when cocultured with 3T3
fibroblasts. Although Fujita et al. (32) also cocultured
BMCMC with 3T3 fibroblasts, the efficiency of the pheno-
typic change was much higher in the former report than in
the latter report. These two experiments are principally
different in one point; 11,3 was added in the former experi-
ment but not in the latter experiment. We added IL3 to the
coculture and obtained the result that was comparable with
the result of Levi-Schaffer et al. (11). This implies the involve-
ment of NGF in the phenotypicchange ofBMCMC induced
by fibroblasts. The amount ofNGF released into the medium
was increased significantly when fibroblasts were cultured in
the presence of BMCMC and IL3. Neither BMCMC alone
nor IL3 alone increased the concentration of NGF in the
medium. There is a possibility that BMCMC activated by
IL-3 enhances the production and/or release of NGF by fibro-
blasts. When anti-NGF mAb was added to the coculture con-
taining BMCMC, fibroblasts, and IL3, the phenotypicchange
ofBMCMC did not occur. This also suggests that NGF pro-
duced by fibroblasts plays an important role in the pheno-
typic change of BMCMC. The effect of mast cells on fibro-
blasts has been reported by Levi-Schaffer et al. (36); they
described that rat PMC stimulated migration and prolifera-
tion of 3T3 fibroblasts.References
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